Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1Endocrine 1

Conditions

Peritoneal Neoplasms 1Ovarian Neoplasms 1Gastric Adenocarcinoma 1Adrenocortical Carcinoma 1

Interventions

Specimen Handling 613pembrolizumab 583Magnetic Resonance Spectroscopy 543Carboplatin 430Cyclophosphamide 380Cisplatin 377Biopsy 366Paclitaxel 314Nivolumab 312Gemcitabine 308Radiotherapy 268Bevacizumab 230Dexamethasone 217fludarabine 205Docetaxel 190durvalumab 188venetoclax 187Oxaliplatin 187Rituximab 174Fluorouracil 174atezolizumab 169Pemetrexed 166Capecitabine 162Radiosurgery 160Doxorubicin 160Radiation 156Ipilimumab 144Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Cytoreduction Surgical Procedures × 90 days × Clear all
NCT03127774 2026-05-06

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Columbia University

Phase 2 Active not recruiting
30 enrolled
EndocrineGynecologic

Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT07178808 2026-05-01

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Banner Health

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT05123807 2026-04-16

Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡